Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6–8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study - Matur, Ramesh V.; Thuluva, Subhash; Gunneri, Subbareddy; Yerroju, Vijay; reddy Mogulla, Rammohan; Thammireddy, Kamal; Paliwal, Piyush; Mahantshetty, Niranjana S.; Ravi, Mandyam Dhati; Prashanth, S.; Verma, Savita; Narayan, Jai Prakash (Vaccine, 2024)
Keywords: Active control; Age groups; Allergy and Immunology; Aluminum; Antibodies; Antibodies, Bacterial - blood; Antigens; burden of disease; Capsular polysaccharides; clinical trials; Conjugate vaccine; Conjugates; cross immunity; Developing countries; Disease; Dosage; Drug dosages; Epidemiology; Fatalities; Female; Hepatitis; Humans; Immune response; Immune system; Immunogenicity; Immunogenicity, Vaccine; Immunoglobulin G; Immunoglobulin G - blood; India; Infant; Infants; LDCs; Male; Meningitis; Opsonophagocytic activity; Pediatrics; Pneumococcal capsular polysaccharide; Pneumococcal disease; Pneumococcal Infections - immunology; Pneumococcal Infections - prevention & control; Pneumococcal Vaccines - administration & dosage; Pneumococcal Vaccines - adverse effects; Pneumococcal Vaccines - immunology; Pneumonia; Polysaccharides; Proteins; Safety; Schedules; Serogroup; Serotype; Serotypes; Single-Blind Method; Streptococcus infections; Streptococcus pneumoniae; Streptococcus pneumoniae - immunology; Vaccines; Vaccines, Conjugate - administration & dosage; Vaccines, Conjugate - adverse effects; Vaccines, Conjugate - immunology; India; Opsonophagocytic activity; Conjugate vaccine; Infants; Pneumococcal disease; Serotype; Pneumococcal capsular polysaccharide; Streptococcus pneumoniae